June 30 (Reuters) - Clinuvel Pharmaceuticals Ltd (CUV) :
- TWO GROUNDS OF APPEAL UPHELD BY NICE PANEL
- ENGLAND'S NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE LOST A SECOND INTERNAL APPEAL
- LOST SECOND INTERNAL APPEAL FOLLOWING DECISION NOT TO RECOMMEND AFAMELANOTIDE FOR USE ON ENGLISH NATIONAL HEALTH SERVICE
News: CUV Clinuvel Pharmaceuticals Says Two Grounds Of Appeal Upheld By Nice Panel
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.85 |
Change
0.330(2.86%) |
Mkt cap ! $599.9M | |||
| Open | High | Low | Value | Volume |
| $11.54 | $12.28 | $11.54 | $1.934M | 161.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 431 | $11.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.87 | 274 | 5 |
View Market Depth
| Last trade - 15.30pm 19/09/2025 (20 minute delay) ? |
| CUV (ASX) Chart |